PATHOS: A phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV)-positive oropharyngeal cancer - Evans, M; Knott, S; Hurt, C (Journal of Clinical Oncology, 2018)